Abeer M. Shaaban
Mindelsohn Way
Birmingham, ENG, United Kingdom
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 180 publications
UK recommendations for Ki-67 immunohistochemical staining and interpretation in breast cancer.
Journal: Histopathology
Published: July 18, 2026
Management of high-risk (B3) breast lesions in symptomatic practice: evidence review and practical recommendations for multidisciplinary care.
Journal: Virchows Archiv : an international journal of pathology
Published: June 19, 2026
Down-Regulation of Proline Rich Homeodomain/Haematopoietically Expressed Homeobox Expression in Prostate Cells Enables Tumour Initiation and Tumour Growth.
Journal: Cancers
Published: March 30, 2026
Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge Gaps.
Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge Gaps.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 20, 2026
A Worldwide Survey on Pathological Measurement of Residual Breast Cancer After Neoadjuvant Therapy: Different Interpretations of the ypTNM Classification.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: December 04, 2025
Prognostic significance of clinicopathological parameters, margin width and locoregional recurrences on outcome of primary and radiation associated breast angiosarcoma- results from a large UK sarcoma regional service.
Journal: Breast cancer research : BCR
Published: October 13, 2025
FAST MRI: DYAMOND trial protocol (can an abbreviated MRI scan detect breast cancers missed by mammography for screening clients with average mammographic density attending their first screening mammogram?)-a diagnostic yield study within the NHS population-risk breast screening programme.
Journal: BMJ open
Published: September 29, 2025
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: July 07, 2025
Inter-rater agreement of HER2-low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797).
Journal: The journal of pathology. Clinical research
Published: May 20, 2025
Discrepancy between mammographic and pathological sizing of screen-detected DCIS: Risk factors and impact on ipsilateral recurrence rates.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: March 14, 2025
HER2-Low Breast Cancer-Current Knowledge and Future Directions.
Journal: Medicina (Kaunas, Lithuania)
Published: March 02, 2025
Last Updated: 09/26/2026